Now showing items 1-1 of 1
Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals
(Journal article; Tidsskriftartikkel; Peer reviewed, 2018-10-23)
Abstract Oncolytic peptides and peptidomimetics are being optimized for the treatment of cancer by selecting agents with high cytotoxic potential to kill a maximum of tumor cells as well as the capacity to trigger anticancer immune responses and hence to achieve long-term effects beyond therapeutic discontinuation. Here, we report on the characterization of two novel oncolytic peptides, DTT-205 ...